Phantomics presented the latest research results related to the diagnosis and analysis of cardiovascular diseases at the RSNA 2021 (Radiological Society of North America), which is the largest radiology conference in the world, held in Chicago from November 28th to December 2nd, 2021, with over 20,000 participants, more than 2,000 research presentations, over 1,500 educational exhibitions, and over 500 state-of-the-art innovations in radiology. At RSNA, Phantomics presented research results related to cardiovascular disease diagnosis and analysis, including an artificial intelligence-based analysis algorithm that can diagnose myocardial disease based on cardiac MRI, an algorithm that corrects measurement errors in imaging biomarkers in healthy individuals without heart disease, and radio-mic studies predicting left ventricular reverse remodeling in patients with non-ischemic dilated cardiomyopathy. Phantomics also exhibited △Myomics-T1, △Myomics-T2, and △Myomics-Lab, which apply AI technology to diagnose cardiovascular disease more easily and quickly. The recently FDA 510K-certified Myomics-Q product received a lot of attention from participants.